Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prescreening Study to Identify Potential Participants for a Clinical Study in Wilson Disease (WD) Due to the ATP7B p.H1069Q or p.R778L Mutations

NCT07226622 is registered in ClinicalTrials.gov with Prime Medicine, Inc. as lead sponsor.

NCT NCT07226622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07226622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prescreening Study to Identify Potential Participants for a Clinical Study in Wilson Disease (WD) Due to the ATP7B p.H1069Q or p.R778L Mutations
Lead sponsor
Prime Medicine, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 29, 2025
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

wilson disease